Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 3Gastrointestinal 2Breast 2NET 1Genitourinary 1Endocrine 1

Conditions

Rectal Neoplasms 1Neuroendocrine Tumors 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoma, Neuroendocrine 1

Interventions

Oxaliplatin 1435Fluorouracil 1316Capecitabine 1112Gemcitabine 1054Leucovorin 935Bevacizumab 845Irinotecan 827Cisplatin 673Radiotherapy 559Cetuximab 481pembrolizumab 435Paclitaxel 400Drug Therapy 358Nivolumab 349130-nm albumin-bound paclitaxel 326Docetaxel 289Sorafenib 288S 1 (combination) 278Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 256lenvatinib 222sintilimab 218tislelizumab 213durvalumab 211regorafenib 208Radiosurgery 204Magnetic Resonance Spectroscopy 203apatinib 202Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Copper × Gastrointestinal × Clear all
NCT05245786 2025-11-10

An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer

City of Hope Medical Center

Phase EARLY_PHASE1 Recruiting
15 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05709171 2023-11-22

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Rigshospitalet, Denmark

Phase 2 Unknown
200 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡